A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers

Takaho Okada, Masanori Akada, Tomonobu Fujita, Takashi Iwata, Yasufumi Goto, Kenji Kido, Tsutomu Okada, Yuriko Matsuzaki, Kouichi Kobayashi, Seiki Matsuno, Makoto Sunamura, Yutaka Kawakami

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Purpose: To isolate cancer testis antigens that are expressed in pancreatic cancers and may be useful in clinical applications. Experimental Design: To efficiently isolate cancer testis antigens, a testis cDNA library was immunoscreened (SEREX) with serum from a patient with pancreatic ductal adenocarcinoma. The expression of isolated antigens in various cancer cell lines and tissues was evaluated by reverse transcription-PCR and Northern blot analyses. The immunogenicity of the antigen in cancer patients was evaluated by detection of the IgG antibody in sera from patients with various cancers. Results: Of the three clones isolated through screening of a total of 2 × 106 cDNA library clones, one clone (KU-CT-1) was found to be expressed in various cancers but only in testis among normal tissues, indicating that it was a novel cancer testis antigen. The KU-CT-1 gene is located on chromosome 10p12 and produces two splice variants, which encode proteins of 397 and 872 amino acids, respectively. KU-CT-1 was expressed in pancreatic cancer tissues (3 of 9, 33%), lung cancer tissues (9 of 24, 38%), and endometrial cancer tissues (7 of 11, 64%). Specific serum IgG antibodies were detected in 3 of 20 pancreatic cancer patients, 2 of 12 endometrial cancer patients, 1 of 18 colon cancer patients, and 1 of 10 prostate cancer patients but not detected in 30 healthy individuals. Conclusions: KU-CT-1 is a new cancer testis antigen that is expressed in pancreatic, lung, and endometrial cancers and may be useful for diagnosis and immunotherapy for patients with various cancers.

Original languageEnglish
Pages (from-to)191-197
Number of pages7
JournalClinical Cancer Research
Volume12
Issue number1
DOIs
Publication statusPublished - 2006 Jan 1

Fingerprint

Testicular Neoplasms
Endometrial Neoplasms
Pancreatic Neoplasms
Lung Neoplasms
Antigens
Clone Cells
Neoplasms
Gene Library
Testis
Immunoglobulin G
Serum
Antibodies
Northern Blotting
Immunotherapy
Colonic Neoplasms
Reverse Transcription
Prostatic Neoplasms
Adenocarcinoma
Research Design
Chromosomes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers. / Okada, Takaho; Akada, Masanori; Fujita, Tomonobu; Iwata, Takashi; Goto, Yasufumi; Kido, Kenji; Okada, Tsutomu; Matsuzaki, Yuriko; Kobayashi, Kouichi; Matsuno, Seiki; Sunamura, Makoto; Kawakami, Yutaka.

In: Clinical Cancer Research, Vol. 12, No. 1, 01.01.2006, p. 191-197.

Research output: Contribution to journalArticle

Okada, T, Akada, M, Fujita, T, Iwata, T, Goto, Y, Kido, K, Okada, T, Matsuzaki, Y, Kobayashi, K, Matsuno, S, Sunamura, M & Kawakami, Y 2006, 'A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers', Clinical Cancer Research, vol. 12, no. 1, pp. 191-197. https://doi.org/10.1158/1078-0432.CCR-05-1206
Okada, Takaho ; Akada, Masanori ; Fujita, Tomonobu ; Iwata, Takashi ; Goto, Yasufumi ; Kido, Kenji ; Okada, Tsutomu ; Matsuzaki, Yuriko ; Kobayashi, Kouichi ; Matsuno, Seiki ; Sunamura, Makoto ; Kawakami, Yutaka. / A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers. In: Clinical Cancer Research. 2006 ; Vol. 12, No. 1. pp. 191-197.
@article{cb3ae784fb5a4db9b7de96d1bdaf8e14,
title = "A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers",
abstract = "Purpose: To isolate cancer testis antigens that are expressed in pancreatic cancers and may be useful in clinical applications. Experimental Design: To efficiently isolate cancer testis antigens, a testis cDNA library was immunoscreened (SEREX) with serum from a patient with pancreatic ductal adenocarcinoma. The expression of isolated antigens in various cancer cell lines and tissues was evaluated by reverse transcription-PCR and Northern blot analyses. The immunogenicity of the antigen in cancer patients was evaluated by detection of the IgG antibody in sera from patients with various cancers. Results: Of the three clones isolated through screening of a total of 2 × 106 cDNA library clones, one clone (KU-CT-1) was found to be expressed in various cancers but only in testis among normal tissues, indicating that it was a novel cancer testis antigen. The KU-CT-1 gene is located on chromosome 10p12 and produces two splice variants, which encode proteins of 397 and 872 amino acids, respectively. KU-CT-1 was expressed in pancreatic cancer tissues (3 of 9, 33{\%}), lung cancer tissues (9 of 24, 38{\%}), and endometrial cancer tissues (7 of 11, 64{\%}). Specific serum IgG antibodies were detected in 3 of 20 pancreatic cancer patients, 2 of 12 endometrial cancer patients, 1 of 18 colon cancer patients, and 1 of 10 prostate cancer patients but not detected in 30 healthy individuals. Conclusions: KU-CT-1 is a new cancer testis antigen that is expressed in pancreatic, lung, and endometrial cancers and may be useful for diagnosis and immunotherapy for patients with various cancers.",
author = "Takaho Okada and Masanori Akada and Tomonobu Fujita and Takashi Iwata and Yasufumi Goto and Kenji Kido and Tsutomu Okada and Yuriko Matsuzaki and Kouichi Kobayashi and Seiki Matsuno and Makoto Sunamura and Yutaka Kawakami",
year = "2006",
month = "1",
day = "1",
doi = "10.1158/1078-0432.CCR-05-1206",
language = "English",
volume = "12",
pages = "191--197",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers

AU - Okada, Takaho

AU - Akada, Masanori

AU - Fujita, Tomonobu

AU - Iwata, Takashi

AU - Goto, Yasufumi

AU - Kido, Kenji

AU - Okada, Tsutomu

AU - Matsuzaki, Yuriko

AU - Kobayashi, Kouichi

AU - Matsuno, Seiki

AU - Sunamura, Makoto

AU - Kawakami, Yutaka

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Purpose: To isolate cancer testis antigens that are expressed in pancreatic cancers and may be useful in clinical applications. Experimental Design: To efficiently isolate cancer testis antigens, a testis cDNA library was immunoscreened (SEREX) with serum from a patient with pancreatic ductal adenocarcinoma. The expression of isolated antigens in various cancer cell lines and tissues was evaluated by reverse transcription-PCR and Northern blot analyses. The immunogenicity of the antigen in cancer patients was evaluated by detection of the IgG antibody in sera from patients with various cancers. Results: Of the three clones isolated through screening of a total of 2 × 106 cDNA library clones, one clone (KU-CT-1) was found to be expressed in various cancers but only in testis among normal tissues, indicating that it was a novel cancer testis antigen. The KU-CT-1 gene is located on chromosome 10p12 and produces two splice variants, which encode proteins of 397 and 872 amino acids, respectively. KU-CT-1 was expressed in pancreatic cancer tissues (3 of 9, 33%), lung cancer tissues (9 of 24, 38%), and endometrial cancer tissues (7 of 11, 64%). Specific serum IgG antibodies were detected in 3 of 20 pancreatic cancer patients, 2 of 12 endometrial cancer patients, 1 of 18 colon cancer patients, and 1 of 10 prostate cancer patients but not detected in 30 healthy individuals. Conclusions: KU-CT-1 is a new cancer testis antigen that is expressed in pancreatic, lung, and endometrial cancers and may be useful for diagnosis and immunotherapy for patients with various cancers.

AB - Purpose: To isolate cancer testis antigens that are expressed in pancreatic cancers and may be useful in clinical applications. Experimental Design: To efficiently isolate cancer testis antigens, a testis cDNA library was immunoscreened (SEREX) with serum from a patient with pancreatic ductal adenocarcinoma. The expression of isolated antigens in various cancer cell lines and tissues was evaluated by reverse transcription-PCR and Northern blot analyses. The immunogenicity of the antigen in cancer patients was evaluated by detection of the IgG antibody in sera from patients with various cancers. Results: Of the three clones isolated through screening of a total of 2 × 106 cDNA library clones, one clone (KU-CT-1) was found to be expressed in various cancers but only in testis among normal tissues, indicating that it was a novel cancer testis antigen. The KU-CT-1 gene is located on chromosome 10p12 and produces two splice variants, which encode proteins of 397 and 872 amino acids, respectively. KU-CT-1 was expressed in pancreatic cancer tissues (3 of 9, 33%), lung cancer tissues (9 of 24, 38%), and endometrial cancer tissues (7 of 11, 64%). Specific serum IgG antibodies were detected in 3 of 20 pancreatic cancer patients, 2 of 12 endometrial cancer patients, 1 of 18 colon cancer patients, and 1 of 10 prostate cancer patients but not detected in 30 healthy individuals. Conclusions: KU-CT-1 is a new cancer testis antigen that is expressed in pancreatic, lung, and endometrial cancers and may be useful for diagnosis and immunotherapy for patients with various cancers.

UR - http://www.scopus.com/inward/record.url?scp=31544439410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544439410&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-05-1206

DO - 10.1158/1078-0432.CCR-05-1206

M3 - Article

C2 - 16397042

AN - SCOPUS:31544439410

VL - 12

SP - 191

EP - 197

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 1

ER -